upper urinary tract urothelial carcinoma
Conditions
Interventions
Experimental group:During radical surgery (intravesical instillation was performed during the handling of the renal dissection, and the installation was emptied before the distal ureteral-cyst sleeve
Controll group:No intravesical perfusion chemotherapy during and after radical surgery
Sponsors
Department of Urology, Peking University First Hospital, Peking University Institute of Urology, National Urological Male Genital Tumor Research Center
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged at least 18 years; 2. No gender limit; 3. After urinary cytology, cystoscopy and CT urography, patients who are clinically considering initial urothelial carcinoma of the upper urinary tract and who are planned to undergo radical renal and ureteral full-length resection; 4. The patient voluntarily participates and signs an informed consent form; 5. Easy to understand and judge the requirements of clinical research.
Exclusion criteria
Exclusion criteria: 1. Patients with a history of bladder tumors; 2. Patients with urothelial carcinoma of the upper urinary tract complicated with bladder tumors; 3. Patients suffering from bilateral upper urinary tract urothelial carcinoma; 4. Patients whose tumor invades nearby organs or reaches perirenal fat through the kidney; 5. According to the judgment of the investigator, there are other patients who are not suitable for clinical research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bladder Recurrence Free Survival (BRFS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence-free survival;Tumor-specific survival rate;Event-free survival; | — |
Countries
China
Contacts
Public ContactZhou Liqun
Peking University First Hospital
Outcome results
None listed